Clinical Trial Update: Neoadjuvant Chemotherapy With Methotrexate, Vinblastine, Adriamycin and Cisplatin (M-VAC) Plus Avastin in Patients With Urothelial Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing neoadjuvant M-VAC chemotherapy with bevacizumab for bladder cancer; the study is completed and results were posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Adriamycin (doxorubicin)
• Avastin (bevacizumab)
• CISPLATIN (cisplatin)
• METHOTREXATE (METHOTREXATE)
• Vinblastine (vinblastine)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-03-31